Amy M. Meyer

554 total citations
12 papers, 469 citations indexed

About

Amy M. Meyer is a scholar working on Pharmacology, Molecular Biology and Physiology. According to data from OpenAlex, Amy M. Meyer has authored 12 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 5 papers in Molecular Biology and 3 papers in Physiology. Recurrent topics in Amy M. Meyer's work include Inflammatory mediators and NSAID effects (6 papers), Nitric Oxide and Endothelin Effects (3 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). Amy M. Meyer is often cited by papers focused on Inflammatory mediators and NSAID effects (6 papers), Nitric Oxide and Endothelin Effects (3 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). Amy M. Meyer collaborates with scholars based in United States, Japan and Spain. Amy M. Meyer's co-authors include Lori D. Dwyer‐Nield, Alvin M. Malkinson, Alison K. Bauer, Lori R. Kisley, Bradley S. Barrett, David C. Thompson, Benjamin L. Barthel, Mark W. Geraci, Robert L. Keith and Robert A. Winn and has published in prestigious journals such as CHEST Journal, Molecular Pharmacology and Carcinogenesis.

In The Last Decade

Amy M. Meyer

12 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy M. Meyer United States 11 265 145 111 108 77 12 469
Tyler M. Hudish United States 8 155 0.6× 83 0.6× 90 0.8× 79 0.7× 53 0.7× 8 343
Labile Togba Soumaoro Japan 6 140 0.5× 101 0.7× 170 1.5× 134 1.2× 42 0.5× 7 405
Gennifer D. Goode United States 7 232 0.9× 167 1.2× 29 0.3× 115 1.1× 41 0.5× 9 381
Eva Sánchez-Galán Spain 7 132 0.5× 61 0.4× 108 1.0× 48 0.4× 20 0.3× 9 408
Misty Brewer United States 12 261 1.0× 110 0.8× 40 0.4× 195 1.8× 36 0.5× 21 435
Wakashi Kitayama Japan 11 187 0.7× 91 0.6× 231 2.1× 71 0.7× 23 0.3× 18 547
Peiyan Hua China 15 367 1.4× 199 1.4× 41 0.4× 87 0.8× 65 0.8× 31 560
Heath A. Elrod United States 6 278 1.0× 80 0.6× 49 0.4× 78 0.7× 22 0.3× 6 365
Eduardo Sandes Argentina 14 178 0.7× 91 0.6× 36 0.3× 35 0.3× 48 0.6× 20 350

Countries citing papers authored by Amy M. Meyer

Since Specialization
Citations

This map shows the geographic impact of Amy M. Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy M. Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy M. Meyer more than expected).

Fields of papers citing papers by Amy M. Meyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy M. Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy M. Meyer. The network helps show where Amy M. Meyer may publish in the future.

Co-authorship network of co-authors of Amy M. Meyer

This figure shows the co-authorship network connecting the top 25 collaborators of Amy M. Meyer. A scholar is included among the top collaborators of Amy M. Meyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy M. Meyer. Amy M. Meyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Nemenoff, Raphael A., Amy M. Meyer, Tyler M. Hudish, et al.. (2008). Prostacyclin Prevents Murine Lung Cancer Independent of the Membrane Receptor by Activation of Peroxisomal Proliferator–Activated Receptor γ. Cancer Prevention Research. 1(5). 349–356. 64 indexed citations
2.
Bren‐Mattison, Yvette, Amy M. Meyer, Vicki Van Putten, et al.. (2007). Antitumorigenic Effects of Peroxisome Proliferator-Activated Receptor-γ in Non-Small-Cell Lung Cancer Cells Are Mediated by Suppression of Cyclooxygenase-2 via Inhibition of Nuclear Factor-κB. Molecular Pharmacology. 73(3). 709–717. 47 indexed citations
3.
Meyer, Amy M., Lori D. Dwyer‐Nield, Gregory J. Hurteau, et al.. (2006). Attenuation of the pulmonary inflammatory response following butylated hydroxytoluene treatment of cytosolic phospholipase A2null mice. American Journal of Physiology-Lung Cellular and Molecular Physiology. 290(6). L1260–L1266. 11 indexed citations
4.
Keith, Robert L., Mark W. Geraci, S. Patrick Nana‐Sinkam, et al.. (2006). Prostaglandin E2 receptor subtype 2 (EP2) null mice are protected against murine lung tumorigenesis.. PubMed. 26(4B). 2857–61. 31 indexed citations
5.
Dwyer‐Nield, Lori D., Bradley S. Barrett, Jin‐Hee Ahn, et al.. (2005). Cytokines differentially regulate the synthesis of prostanoid and nitric oxide mediators in tumorigenic versus non-tumorigenic mouse lung epithelial cell lines. Carcinogenesis. 26(7). 1196–1206. 22 indexed citations
6.
Meyer, Amy M.. (2004). Decreased lung tumorigenesis in mice genetically deficient in cytosolic phospholipase A2. Carcinogenesis. 25(8). 1517–1524. 73 indexed citations
7.
Zerbe, Laura K., Irene Pino, Rubén Pı́o, et al.. (2004). Relative amounts of antagonistic splicing factors, hnRNP A1 and ASF/SF2, change during neoplastic lung growth: Implications for pre‐mRNA processing. Molecular Carcinogenesis. 41(4). 187–196. 61 indexed citations
8.
Pao, William, Sonia B. Jakowlew, Amy M. Meyer, et al.. (2004). Serum Levels of Surfactant Protein D Are Increased in Mice With Lung Tumors. CHEST Journal. 125(5). 109S–109S. 18 indexed citations
9.
Zhang, Feijie, William Pao, Sonia B. Jakowlew, et al.. (2003). Serum levels of surfactant protein D are increased in mice with lung tumors.. PubMed. 63(18). 5889–94. 21 indexed citations
10.
Kisley, Lori R., Bradley S. Barrett, Alison K. Bauer, et al.. (2002). Genetic ablation of inducible nitric oxide synthase decreases mouse lung tumorigenesis.. PubMed. 62(23). 6850–6. 102 indexed citations
11.
Malkinson, A M, Alison K. Bauer, Amy M. Meyer, et al.. (2000). Experimental Evidence From an Animal Model of Adenocarcinoma That Chronic Inflammation Enhances Lung Cancer Risk. CHEST Journal. 117(5). 228S–228S. 18 indexed citations
12.
Meyer, Amy M.. (1954). [Adenocarcinoma of the urachus].. PubMed. 47(8). 512–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026